open access

Ahead of print
Case Reports
Published online: 2019-03-27
Get Citation

Acute stent malfunction in a fibrocalcific lesion

Santosh Kumar Sinha, Puneet Aggarwal, Lokendra Rekwal, Anupam Singh
DOI: 10.5603/FC.a2019.0022

open access

Ahead of print
Case Reports
Published online: 2019-03-27

Abstract

Stent fracture is an emerging complication of coronary angioplasty as a result of the complex interplay between stent design, the stented segment, stent over-expansion, a long stent and tortuous and complex lesions including chronic totally occluded vessels and calcified lesions.Its temporal course may be acute as well as delayed, including totally asymptomatic restenosis, migration of the stent, vessel perforation, and stent thrombosis. Here, we report the case of a 60 year-old patient who had acute stent fracture of an Endeavour Resolute stent (zotarolimus-eluting stent 3 × 33 mm) in a fibrocalcific lesion causing vessel perforation which was successfully treated with restenting by another Endeavour Resolute stent (3 × 29 mm).

Abstract

Stent fracture is an emerging complication of coronary angioplasty as a result of the complex interplay between stent design, the stented segment, stent over-expansion, a long stent and tortuous and complex lesions including chronic totally occluded vessels and calcified lesions.Its temporal course may be acute as well as delayed, including totally asymptomatic restenosis, migration of the stent, vessel perforation, and stent thrombosis. Here, we report the case of a 60 year-old patient who had acute stent fracture of an Endeavour Resolute stent (zotarolimus-eluting stent 3 × 33 mm) in a fibrocalcific lesion causing vessel perforation which was successfully treated with restenting by another Endeavour Resolute stent (3 × 29 mm).

Get Citation

Keywords

fibrocalcific lesion; perforation; restenosis; stent fracture; stent migration

About this article
Title

Acute stent malfunction in a fibrocalcific lesion

Journal

Folia Cardiologica

Issue

Ahead of print

Published online

2019-03-27

DOI

10.5603/FC.a2019.0022

Keywords

fibrocalcific lesion
perforation
restenosis
stent fracture
stent migration

Authors

Santosh Kumar Sinha
Puneet Aggarwal
Lokendra Rekwal
Anupam Singh

References (10)
  1. Aoki J, Nakazawa G, Tanabe K, et al. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv. 2007; 69(3): 380–386.
  2. Lee MS, Jurewitz D, Aragon J, et al. Stent fracture associated with drug-eluting stents: clinical characteristics and implications. Catheter Cardiovasc Interv. 2007; 69(3): 387–394.
  3. Sianos G, Hofma S, Ligthart JMR, et al. Stent fracture and restenosis in the drug-eluting stent era. Catheter Cardiovasc Interv. 2004; 61(1): 111–116.
  4. Kim HS, Kim YH, Lee SW, et al. Long-DES-II study investigators. Incidence and predictors of drug-eluting stent fractures in long coronary disease. Int J Cardiol. 2009; 133(3): 354–358.
  5. Nakazawa G, Finn AV, Vorpahl M, et al. Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. J Am Coll Cardiol. 2009; 54(21): 1924–1931.
  6. Shite J, Matsumoto D, Yokoyama M. Sirolimus-eluting stent fracture with thrombus, visualization by optical coherence tomography. Eur Heart J. 2006; 27(12): 1389.
  7. Park JS, Shin DG, Kim YJ, et al. Acute myocardial infarction as a consequence of stent fracture and plaque rupture after sirolimus-eluting stent implantation. Int J Cardiol. 2009; 134(2): e79–e81.
  8. Makaryus AN, Lefkowitz L, Lee ADK. Coronary artery stent fracture. Int J Cardiovasc Imaging. 2007; 23(3): 305–309.
  9. Kang WYu, Kim W, Hwang SHo, et al. Dark side of drug-eluting stent: multiple stent fractures and sudden death. Int J Cardiol. 2009; 132(3): e125–e127.
  10. Shinde RS, Hardas S, Grant PK, et al. Stent fracture detected with a novel fluoroscopic stent visualization technique - StentBoost. Can J Cardiol. 2009; 25(8): 487.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl